Literature DB >> 8604177

Malaria, the submerged disease.

P Olliaro1, J Cattani, D Wirth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8604177

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  20 in total

1.  Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.

Authors:  A Singh; P J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.

Authors:  A Moreno; E Badell; N Van Rooijen; P Druilhe
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Antimalarial synergy of cysteine and aspartic protease inhibitors.

Authors:  A Semenov; J E Olson; P J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

4.  Potentiation of the antimalarial agent rufigallol.

Authors:  R W Winter; K A Cornell; L L Johnson; M Ignatushchenko; D J Hinrichs; M K Riscoe
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

5.  In vitro and in vivo antimalarial efficacies of optimized tetracyclines.

Authors:  Michael P Draper; Beena Bhatia; Haregewein Assefa; Laura Honeyman; Lynne K Garrity-Ryan; Atul K Verma; Jiri Gut; Kelley Larson; Janice Donatelli; Ann Macone; Kevin Klausner; Raina G Leahy; Aleksandrs Odinecs; Kwasi Ohemeng; Philip J Rosenthal; Mark L Nelson
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

Review 6.  Artemisinin derivatives for treating uncomplicated malaria.

Authors:  H M McIntosh; P Olliaro
Journal:  Cochrane Database Syst Rev       Date:  2000

7.  Evaluation of the OptiMAL test for rapid diagnosis of Plasmodium vivax and Plasmodium falciparum malaria.

Authors:  C J Palmer; J F Lindo; W I Klaskala; J A Quesada; R Kaminsky; M K Baum; A L Ager
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

8.  Analysis of antimalarial synergy between bestatin and endoprotease inhibitors using statistical response-surface modelling.

Authors:  C S Gavigan; S G Machado; J P Dalton; A Bell
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum.

Authors:  Subash Chandra Mohapatra; Hemandra Kumar Tiwari; Manisha Singla; Brijesh Rathi; Arun Sharma; Kuldeep Mahiya; Mukesh Kumar; Saket Sinha; Shyam Singh Chauhan
Journal:  J Biol Inorg Chem       Date:  2009-11-28       Impact factor: 3.358

10.  Differential impact of sickle cell trait on symptomatic and asymptomatic malaria.

Authors:  Eunha Shim; Zhilan Feng; Carlos Castillo-Chavez
Journal:  Math Biosci Eng       Date:  2012-10       Impact factor: 2.080
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.